-
1
-
-
0029814477
-
Long-term consequences of Kawasaki disease
-
H. Kato, T. Sugiyama, T. Akagi, N. Sato, K. Hashino, Y. Maeno, T. Kazue, G. Eto, R. Yamakawa Long-term consequences of Kawasaki disease Circulation 94 1996 1379 1385
-
(1996)
Circulation
, vol.94
, pp. 1379-1385
-
-
Kato, H.1
Sugiyama, T.2
Akagi, T.3
Sato, N.4
Hashino, K.5
Maeno, Y.6
Kazue, T.7
Eto, G.8
Yamakawa, R.9
-
2
-
-
0021702429
-
High-dose intravenous gammaglobulin for Kawasaki disease
-
K. Furusho, T. Kamiya, N. Kiyosawa, K. Shinomiya, T. Hayashidera, T. Tamura, O. Hirose, Y. Manabe, T. Yokoyama High-dose intravenous gammaglobulin for Kawasaki disease Lancet 10 1984 1055 1058
-
(1984)
Lancet
, vol.10
, pp. 1055-1058
-
-
Furusho, K.1
Kamiya, T.2
Kiyosawa, N.3
Shinomiya, K.4
Hayashidera, T.5
Tamura, T.6
Hirose, O.7
Manabe, Y.8
Yokoyama, T.9
-
3
-
-
0030028803
-
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids
-
D.A. Wright, J.W. Newburger, A. Baker, R.P. Sundel Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids J Pediatr 128 1996 146 149
-
(1996)
J Pediatr
, vol.128
, pp. 146-149
-
-
Wright, D.A.1
Newburger, J.W.2
Baker, A.3
Sundel, R.P.4
-
4
-
-
84971768455
-
Pathological observations concerning the cardiovascular lesions in Kawasaki disease
-
S. Naoe, K. Shibuya, K. Takahashi, M. Wakayama, H. Masuda, N. Tanaka Pathological observations concerning the cardiovascular lesions in Kawasaki disease Cardiol Young 1 1991 212 220
-
(1991)
Cardiol Young
, vol.1
, pp. 212-220
-
-
Naoe, S.1
Shibuya, K.2
Takahashi, K.3
Wakayama, M.4
Masuda, H.5
Tanaka, N.6
-
5
-
-
0034117527
-
Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease
-
M. Zaitsu, Y. Hamasaki, K. Tashiro, M. Matsuo, T. Ichimaru, I. Fujita, H. Tasaki, S. Miyazaki Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease J Infect Dis 181 2000 1101 1109
-
(2000)
J Infect Dis
, vol.181
, pp. 1101-1109
-
-
Zaitsu, M.1
Hamasaki, Y.2
Tashiro, K.3
Matsuo, M.4
Ichimaru, T.5
Fujita, I.6
Tasaki, H.7
Miyazaki, S.8
-
6
-
-
0033603241
-
RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides
-
M.A. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P Nawroth RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
-
(1999)
Cell
, vol.97
, pp. 889-901
-
-
Hofmann, M.A.1
Drury, S.2
Fu, C.3
Qu, W.4
Taguchi, A.5
Lu, Y.6
Avila, C.7
Kambham, N.8
Bierhaus, A.9
Nawroth, P.10
-
7
-
-
0034795140
-
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
-
A.M. Schmidt, S.D. Yan, S.F. Yan, D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 2001 949 955
-
(2001)
J Clin Invest
, vol.108
, pp. 949-955
-
-
Schmidt, A.M.1
Yan, S.D.2
Yan, S.F.3
Stern, D.M.4
-
8
-
-
0242500281
-
S100A12 (EN-RAGE) in monitoring Kawasaki disease
-
D. Foell, F. Ichida, T. Vogl, X. Yu, R. Chen, T. Miyawaki, C. Sorg, J. Roth S100A12 (EN-RAGE) in monitoring Kawasaki disease Lancet 361 2003 1270 1272
-
(2003)
Lancet
, vol.361
, pp. 1270-1272
-
-
Foell, D.1
Ichida, F.2
Vogl, T.3
Yu, X.4
Chen, R.5
Miyawaki, T.6
Sorg, C.7
Roth, J.8
-
9
-
-
0035198035
-
Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease
-
Y. Hamamichi, F. Ichida, Yu Xianyi, K. Uese, S. Tsubata, I. Hashimoto, T. Futatani, H. Kanegane, T. Miyawaki Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease Pediatr Res 49 2001 74 80
-
(2001)
Pediatr Res
, vol.49
, pp. 74-80
-
-
Hamamichi, Y.1
Ichida, F.2
Yu, X.3
Uese, K.4
Tsubata, S.5
Hashimoto, I.6
Futatani, T.7
Kanegane, H.8
Miyawaki, T.9
-
11
-
-
0040886358
-
S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14
-
T. Vogl, C. Propper, M. Hartmann, A. Strey, K. Strupat, Bos C. Van den, C. Sorg, J. Roth S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14 J Biol Chem 274 1999 25291 25296
-
(1999)
J Biol Chem
, vol.274
, pp. 25291-25296
-
-
Vogl, T.1
Propper, C.2
Hartmann, M.3
Strey, A.4
Strupat, K.5
Van Den Bos, C.6
Sorg, C.7
Roth, J.8
-
12
-
-
19244372556
-
Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection
-
T. Futatani, T. Miyawaki, S. Tsukada, S. Hashimoto, T. Kunikata, S. Arai, M. Kurimoto, Y. Niida, H. Matsuoka, Y Sakiyama Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection Blood 91 1998 595 602
-
(1998)
Blood
, vol.91
, pp. 595-602
-
-
Futatani, T.1
Miyawaki, T.2
Tsukada, S.3
Hashimoto, S.4
Kunikata, T.5
Arai, S.6
Kurimoto, M.7
Niida, Y.8
Matsuoka, H.9
Sakiyama, Y.10
-
13
-
-
0038576426
-
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease
-
D. Foell, T. Kucharzik, M. Kraft, T. Vogl, C. Sorg, W. Domschke, J. Roth Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease Gut 52 2003 847 853
-
(2003)
Gut
, vol.52
, pp. 847-853
-
-
Foell, D.1
Kucharzik, T.2
Kraft, M.3
Vogl, T.4
Sorg, C.5
Domschke, W.6
Roth, J.7
-
14
-
-
0034972364
-
Proinflammatory properties of the human S100 protein S100A12
-
Z. Yang, T. Tao, M.J. Raftery, P. Youssef, N.D. Girolamo, C.L. Geczy Proinflammatory properties of the human S100 protein S100A12 J Leukoc Biol 69 2001 986 994
-
(2001)
J Leukoc Biol
, vol.69
, pp. 986-994
-
-
Yang, Z.1
Tao, T.2
Raftery, M.J.3
Youssef, P.4
Girolamo, N.D.5
Geczy, C.L.6
|